Patients who are 45 or older when they have surgery for Cushing’s disease are more likely to need long-term hormone replacement therapy, according to a new study. Researchers found that prolonged medication use, lasting 20 months or more, is associated with lower survival odds for those with pituitary-driven Cushing’s.